By Swapan Das, Calcutta
LAENNEC PLACENTA - A human placenta based product, is the result of research done at JBP research center in Kurume, Japan headed by Dr. Akira Yagi. Established in 1936, Japan Bio Products Co., Ltd. today is the world's largest manufacturer of Pharmaceuticals derived from Human Placental extracts by volume. Licensed by Japanese Ministry of Health & welfare in 1974 to commercialize Laennec inj., a drug developed by proprietary extraction process, is used to treat liver dysfunction in patients suffering from Liver Cirrhosis & Hepatitis, with GMP certification. Current manufacturing facilities include Kurume factory in Japan & Eumsung in Seoul, South Korea.
|Laennec Placenta - Japan|
LAENNEC is said to be a government subsidized drug for Japanese patients seeking treatment for Hepatitis and liver cirrhosis. The Japan’s National Health Insurance covers placental treatments for liver disease and symptoms of menopause. It is a “specialized designated drug”, a prescribed drug, holds license as an ethical drug. This drug is manufactured under the supervision of pharmaceutical affairs law of Japan as per the GMP guidelines. It claims to have set up a vast global network, touching the boundaries of nations like Japan, Korea, Russia, USA, Singapore, Malaysia, Taiwan, and China.
Readers may visit the following links to know more about this Product and the Manufacturer: